Search Results - "Packard, C. J"

Refine Results
  1. 1

    Measurement and meaning of apolipoprotein AI and apolipoprotein B plasma levels by MARCOVINA, S., PACKARD, C. J.

    Published in Journal of internal medicine (01-05-2006)
    “… Apolipoproteins AI and B are structural components of lipoprotein particles, and also determinants of the metabolic fate of the encapsulated lipid,…”
    Get full text
    Journal Article
  2. 2

    Investigation of human apoB48 metabolism using a new, integrated non‐steady‐state model of apoB48 and apoB100 kinetics by Björnson, E., Packard, C. J., Adiels, M., Andersson, L., Matikainen, N., Söderlund, S., Kahri, J., Sihlbom, C., Thorsell, A., Zhou, H., Taskinen, M.‐R., Borén, J.

    Published in Journal of internal medicine (01-05-2019)
    “…Background Triglyceride‐rich lipoproteins and their remnants have emerged as major risk factors for cardiovascular disease. New experimental approaches are…”
    Get full text
    Journal Article
  3. 3
  4. 4

    Triacylglycerol-rich lipoproteins and the generation of small, dense low-density lipoprotein by Packard, C J

    Published in Biochemical Society transactions (01-10-2003)
    “…LDL (low-density lipoprotein) is the major carrier of cholesterol in human plasma, and as such is intimately involved in the process of atherosclerosis. The…”
    Get more information
    Journal Article
  5. 5

    Peroxisome proliferator activated receptor delta genotype in relation to cardiovascular risk factors and risk of coronary heart disease in hypercholesterolaemic men by Skogsberg, J., McMahon, A. D., Karpe, F., Hamsten, A., Packard, C. J., Ehrenborg, E.

    Published in Journal of internal medicine (01-12-2003)
    “… Objectives.  Peroxisome proliferator activated receptor delta (PPARD) is a transcription factor implicated in the regulation of genes involved in cholesterol…”
    Get full text
    Journal Article
  6. 6

    Defective regulation of triglyceride metabolism by insulin in the liver in NIDDM by MALMSTRÖM, R, PACKARD, C. J, CASLAKE, M, BEDFORD, D, STEWART, P, YKI-JÄRVINEN, H, SHEPHERD, J, TASKINEN, M.-R

    Published in Diabetologia (01-04-1997)
    “…Insulin administration to healthy subjects inhibits the production of very low density lipoprotein (VLDL)1 (Svedbergs flotation (Sf) rate 60-400) without…”
    Get full text
    Journal Article
  7. 7

    Lipids and lipoprotein subfractions in women with PCOS: relationship to metabolic and endocrine parameters by Pirwany, I. R., Fleming, R., Greer, I. A., Packard, C. J., Sattar, N.

    Published in Clinical endocrinology (Oxford) (01-04-2001)
    “…OBJECTIVE Women with polycystic ovary syndrome (PCOS) exhibit an abnormal lipoprotein profile, characterized by raised concentrations of plasma triglyceride,…”
    Get full text
    Journal Article
  8. 8

    Exercise training has greater effects on insulin sensitivity in daughters of patients with type 2 diabetes than in women with no family history of diabetes by Barwell, N. D, Malkova, D, Moran, C. N, Cleland, S. J, Packard, C. J, Zammit, V. A, Gill, J. M. R

    Published in Diabetologia (01-10-2008)
    “…Aims/hypothesis Sedentary offspring of patients with type 2 diabetes are often more insulin-resistant than persons with no family history of diabetes, but when…”
    Get full text
    Journal Article
  9. 9

    Genetic variation in the interleukin-1β-converting enzyme associates with cognitive function. The PROSPER study by Trompet, S., de Craen, A. J. M., Slagboom, P., Shepherd, J., Blauw, G. J., Murphy, M. B., Bollen, E. L. E. M., Buckley, B. M., Ford, I., Gaw, A., Macfarlane, P. W., Packard, C. J., Stott, D. J., Jukema, J. W., Westendorp, R. G. J.

    Published in Brain (London, England : 1878) (01-04-2008)
    “…Inflammation is thought to play an important role in the development of cognitive decline and dementia in old age. The interleukin-1 signalling pathway may…”
    Get full text
    Journal Article
  10. 10

    Lipoprotein Heterogeneity and Apolipoprotein B Metabolism by Packard, Chris J, Shepherd, James

    “…The apolipoprotein B containing lipoproteins VLDL, IDL, and LDL exhibit variation in their structure, function, and metabolism. These major lipoprotein classes…”
    Get full text
    Journal Article
  11. 11

    Apolipoprotein B metabolism and the distribution of VLDL and LDL subfractions by Packard, C J, Demant, T, Stewart, J P, Bedford, D, Caslake, M J, Schwertfeger, G, Bedynek, A, Shepherd, J, Seidel, D

    Published in Journal of lipid research (01-02-2000)
    “…Apolipoprotein B (apoB) metabolism was investigated in 20 men with plasma triglyceride 0.66-2.40 mmol/l and plasma cholesterol 3.95-6. 95 mmol/l. Kinetics of…”
    Get full text
    Journal Article
  12. 12

    Testing cognitive function in elderly populations: the PROSPER study by Houx, P J, Shepherd, J, Blauw, G-J, Murphy, M B, Ford, I, Bollen, E L, Buckley, B, Stott, D J, Jukema, W, Hyland, M, Gaw, A, Norrie, J, Kamper, A M, Perry, I J, MacFarlane, P W, Meinders, A Edo, Sweeney, B J, Packard, C J, Twomey, C, Cobbe, S M, Westendorp, R G

    “…Objectives: For large scale follow up studies with non-demented patients in which cognition is an endpoint, there is a need for short, inexpensive, sensitive,…”
    Get full text
    Journal Article
  13. 13

    Influence of plasma lipid and LDL-subfraction profile on the interaction between low density lipoprotein with human arterial wall proteoglycans by Anber, V., Griffin, B.A., McConnell, M., Packard, C.J., Shepherd, J.

    Published in Atherosclerosis (02-08-1996)
    “…Low density lipoprotein (LDL) is known to bind to arterial wall proteoglycans (APG), an interaction which may initiate cholesterol deposition in the arterial…”
    Get full text
    Journal Article
  14. 14

    Effects of insulin and acipimox on VLDL1 and VLDL2 apolipoprotein B production in normal subjects by Malmström, R, Packard, C J, Caslake, M, Bedford, D, Stewart, P, Yki-Järvinen, H, Shepherd, J, Taskinen, M R

    Published in Diabetes (New York, N.Y.) (01-05-1998)
    “…Effects of insulin and acipimox on VLDL1 and VLDL2 apolipoprotein B production in normal subjects. R Malmström , C J Packard , M Caslake , D Bedford , P…”
    Get full text
    Journal Article
  15. 15

    Prospective analysis of the association of infection with CagA bearing strains of Helicobacter pylori and coronary heart disease by Singh, R K, McMahon, A D, Patel, H, Packard, C J, Rathbone, B J, Samani, N J

    Published in Heart (British Cardiac Society) (01-07-2002)
    “…Objective: To see whether it was possible to replicate in a prospective study the association recently reported between infection with the more virulent (type…”
    Get full text
    Journal Article
  16. 16
  17. 17

    Plasma C reactive protein concentration indicates a direct relation between systemic inflammation and social deprivation by St J O’Reilly, D, Upton, M N, Caslake, M J, Robertson, M, Norrie, J, McConnachie, A, Watt, G C M, Packard, C J

    Published in Heart (British Cardiac Society) (01-04-2006)
    “…An increase in the plasma concentration of C reactive protein (CRP), within the reference range for the population but below the threshold that indicates…”
    Get full text
    Journal Article
  18. 18

    Overview of fenofibrate by PACKARD, C. J

    Published in European heart journal (01-02-1998)
    “…Fenofibrate is a broad spectrum lipid-lowering agent able to produce substantial reductions in plasma triglyceride and low density lipoprotein (LDL) and an…”
    Get full text
    Conference Proceeding Journal Article
  19. 19
  20. 20

    Interaction of Very-Low-Density, Intermediate-Density, and Low-Density Lipoproteins With Human Arterial Wall Proteoglycans by Anber, V, Millar, J.S, McConnell, M, Shepherd, J, Packard, C.J

    “…The specific interaction of lipoproteins with arterial wall constituents, particularly proteoglycans (APG), is believed to play an important role in the…”
    Get full text
    Journal Article